Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Capsaicin + menthol + methyl salicylate is a topical combination drug used for the temporary relief of minor aches and pains of muscles and joints associated with arthritis, simple backache, strains, sprains, muscle soreness, and related conditions. - **Capsaicin** acts by depleting substance P from sensory nerve endings in the skin, which reduces pain signal transmission. - **Menthol** provides a cooling sensation by activating cold-sensitive TRPM8 receptors on the skin; this counter-irritant effect distracts from deeper musculoskeletal pain. - **Methyl salicylate** is a rubefacient that increases blood flow to the area and also acts as a counter-irritant through vasodilation and mild local irritation. The combination is available over-the-counter (OTC) in various creams or ointments. It does not treat underlying causes but provides symptomatic relief. These products are generally considered safe when used as directed but can cause local skin reactions such as burning or irritation; rare cases of serious burns have been reported with high concentrations or improper use[3][6]. The product should not be applied to broken or irritated skin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on capsaicin + menthol + methyl salicylate.